ICAM1 and pancreatic adenocarcinoma: Poly(I:C) treatment of pancreatic adenocarcinomas resulted in overexpression of CD54 and concomitant coculture of tumor cells with γδ T cells led to interaction between CD54 and its ligand CD11a/CD18 triggering effector function in γδ T cells.